Status
Conditions
About
The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.
Full description
Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo daily blood, urine and sputum sampling during their stay in intensive care. Data on organ dysfunction will be collected through the electronic patient journal and electronic patient data management system. The collected samples will be analysed for a panel of potential biomarkers that will be correlated to organ dysfunction and clinical outcome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
380 participants in 1 patient group
Loading...
Central trial contact
Sara Bülow Anderberg, MD.; Robert Frithiof, MD. PhD.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal